Chat with us, powered by LiveChat

GIOSTAR Chicago

GIOSTAR Chicago offers cutting-edge regenerative medicine techniques and protocols that have been extensively researched and developed by our leading scientists. Our team consists of world-renowned authorities in stem cell biology, protein biochemistry, molecular biology, immunology, in utero transplantation of stem cell, tissue targeting, gene therapy and clinical research. GIOSTAR Chicago physicians are highly-credential health care professionals, offering personalized patient care to patients suffering from a broad range of degenerative diseases.

Scientific Review: Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients GIOSTAR | Potential Benefits of Stem Cells on COVID-19

Scientific Review: Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients

GIOSTAR leaders recently wrote on the potential benefits of stem cells in combating COVID-19. Published in Stem Cell Reviews and Reports, the review was written by Drs. Anand Srivastava, Prabhat Soni, Diana Esquivel, Rangnath Mishra, Rajasekar Seetharaman, and Anjum Mahmood

GIOSTAR Reports on a Positive Outcome of a COVID-19 Patient After Stem Cell Treatment GIOSTAR | COVID-19 | Positive Outcome

GIOSTAR Reports on a Positive Outcome of a COVID-19 Patient After Stem Cell Treatment

GIOSTAR recently treated a patient suffering from COVID-19 with stem cells. He experienced considerable improvement following this procedure. A placebo-controlled, double-blind study would be needed to better understand the measurable outcome of stem cell treatment for COVID-19.

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic Drs. Anand Srivastava, Prabhat Soni - GIOSTAR

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic

Drs. Anand Srivastava and Prabhat Soni write in a medical journal on the potential benefits of stem cells in fighting against COVID-19. GIOSTAR recently received FDA Approval Under Compassionate Use to treat COVID-19 patients under compassionate use.